A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Eli Lilly and Company
View at source ↗Clinical trial
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-30; modifications: selected fields only (title, sponsor, status, phase, dates); reformatted. Not a U.S. Government endorsement.
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Trial details
- status
- COMPLETED
- phase
- PHASE3
- start date
- 2023-07-11
- start date type
- ACTUAL
- data source
- ClinicalTrials.gov
- data processed
- 2026-10-30
- modifications
- selected fields only (title, sponsor, status, phase, dates); reformatted
Record
- Archive ID
- nct:NCT05929079
- Published
- Jul 3, 2023
- Venue
- ClinicalTrials.gov
- ClinicalTrials.gov
- NCT05929079
- License
- ClinicalTrials.gov terms (attribution, processing date, modifications noted)
- Provenance
- clinicaltrials